In this issue:
- QOL 3 and 12 months after acute PE
- Pretest probability score for suspected PE
- Anticoagulation in cancerassociated VTE: patient preferences
- Adverse events with aspirin + DOAC without a clear indication
- Sotatercept for PAH
- PE prevalence in hospitalised COPD
- Noninvasive early exclusion of CTEPH after acute PE
- Switching to riociguat vs. PDE-5 inhibitor maintenance in PAH
- B-cell depletion with rituximab for systemic sclerosis-PAH
- Risk reduction and haemodynamics with initial combination therapy in PAH
- Iron supplementation in PAH
- Mobile health intervention increases physical activity in PAH
Please login below to download this issue (PDF)